Skip to main content
See every side of every news story
Published loading...Updated

The Diet Drug Insurers Don’t Want to Pay for Just Got Easier to Find

The partnership offers Zepbound vials at nearly 4,600 Walmart pharmacies with direct-to-consumer pricing up to 50% below typical incretin medicine costs.

  • On October 29, 2025, Eli Lilly and Company and Walmart Inc. announced a collaboration to expand direct-to-consumer pricing for Zepbound single-dose vials through LillyDirect.
  • LillyDirect executives say the growth underscores the momentum behind a more modern, consumer-driven model of care, aiming to expand access and ease treatment management.
  • Zepbound vials will be available for pickup at Walmart pharmacies nationwide by mid-November, with self-pay pricing starting at $349 per month for 2.5 mg and $499 for higher doses, Eli Lilly said.
  • LillyDirect's growth data show approximately 35% of new Zepbound prescriptions were fulfilled through LillyDirect in the second quarter of 2025, highlighting its rise as a consumer-driven channel.
  • Walmart's scale means its 270 million customers weekly across more than 10,750 stores and over 50,000 pharmacy staff could boost Eli Lilly's nearly 150 years of history against Novo Nordisk.
Insights by Ground AI

22 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 69% of the sources are Center
69% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Beauty Independent broke the news in on Wednesday, October 29, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal